Predictors of one-year clinically driven revascularization following endovascular treatment of isolated atherosclerotic popliteal artery lesions

预测孤立性腘动脉粥样硬化病变经血管内治疗后一年内临床驱动的血管重建术的因素

阅读:1

Abstract

Isolated atherosclerotic popliteal artery lesions (IAPAL) commonly require interventional treatment. This study aimed to develop a prediction model using procedure-related variables for one-year clinically driven target lesion revascularization (CDTLR) events after intervention. Clinical data were retrospectively collected from 217 patients who underwent endovascular treatment for isolated atherosclerotic popliteal artery lesions between 2017 and 2022. Based on inclusion and exclusion criteria, all patients were randomly divided into training and testing sets at a ratio of 7:3. In the training set, LASSO regression, logistic regression, and random forest were used to identify the most significant variables for outcome events. These variables were then incorporated into a multivariate logistic regression model. The prediction model was visualized using a nomogram and validated using training and testing sets. The final nomogram consisted of three independent predictors: body weight, drug-coating balloon angioplasty, and post-procedural outflow score. The regression equation was: Y = 3.65–0.0645×weight − 1.04×(DCB = use) − 1.21×(post-procedural outflow score = 2) − 0.465×(post-procedural outflow score = 3). The prediction model demonstrated C-indices of 0.756 and 0.689 in the training and validation cohorts, respectively. Calibration curves showed satisfactory agreement in both cohorts. The prediction model incorporating body weight, drug-coating balloon angioplasty, and post-procedural outflow score may assist in predicting one-year clinically driven target lesion revascularization in patients with isolated atherosclerotic popliteal artery lesions, providing valuable information for individualized treatment strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-025-17283-9.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。